Comments on: Real-life cost and cost-effectiveness for tiotropium 18 μg od monotherapy in moderate and severe COPD patients: a 48-month survey

Comments on: Real-life cost and cost-effectiveness for tiotropium 18 μg od monotherapy in moderate and severe COPD patients: a 48-month survey https://adreshe.com/en/real-life-cost-and-cost-effectiveness-for-tiotropium-18-%ce%bcg-od-monotherapy-in-moderate-and-severe-copd-patients-a-48-month-survey/ Health Economics & Outcomes Research Mon, 09 Sep 2024 11:02:18 +0000 hourly 1 https://wordpress.org/?v=6.9.4